Literature DB >> 22154760

Spatial memory deficits in a virtual reality eight-arm radial maze in schizophrenia.

Elena A Spieker1, Robert S Astur, Jeffrey T West, Jacqueline A Griego, Laura M Rowland.   

Abstract

Learning and memory impairments are present in schizophrenia (SZ) throughout the illness course and predict psychosocial function. Abnormalities in prefrontal and hippocampal function are thought to contribute to SZ deficits. The radial arm maze (RAM) is a test of spatial learning and memory in rodents that relies on intact prefrontal and hippocampal function. The goal of the present study was to investigate spatial learning in SZ using a virtual RAM. Thirty-three subjects with SZ and thirty-nine healthy controls (HC) performed ten trials of a virtual RAM task. Subjects attempted to learn to retrieve four rewards each located in separate arms. As expected, subjects with SZ used more time and traveled more distance to retrieve rewards, made more reference (RM) and working memory (WM) errors, and retrieved fewer rewards than HC. It is important to note that the SZ group did learn but did not reach the level of HC. Whereas RM errors decreased across trials in the SZ group, WM errors did not. There were no significant relationships between psychiatric symptom severity and maze performance. To our knowledge, use of a virtual 8-arm radial maze task in SZ to assess spatial learning is novel. Impaired virtual RAM performance in SZ is consistent with studies that examined RAM performance in animal models of SZ. Results provide further support for compromised prefrontal and hippocampal function underlying WM and RM deficits in SZ. The virtual RAM task could help bridge preclinical and clinical research for testing novel drug treatments of SZ.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22154760      PMCID: PMC3288352          DOI: 10.1016/j.schres.2011.11.014

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  45 in total

1.  Repeated phencyclidine treatment induces negative symptom-like behavior in forced swimming test in mice: imbalance of prefrontal serotonergic and dopaminergic functions.

Authors:  Y Noda; H Kamei; T Mamiya; H Furukawa; T Nabeshima
Journal:  Neuropsychopharmacology       Date:  2000-10       Impact factor: 7.853

2.  CUtLASS confirms CATIE.

Authors:  Jim Mintz; Alex Kopelowicz
Journal:  Arch Gen Psychiatry       Date:  2007-08

3.  The effects of chronic administration of quetiapine on the phencyclidine-induced reference memory impairment and decrease of Bcl-XL/Bax ratio in the posterior cingulate cortex in rats.

Authors:  Jue He; Haiyun Xu; Yi Yang; Derek Rajakumar; Xiaokun Li; Xin-Min Li
Journal:  Behav Brain Res       Date:  2005-12-19       Impact factor: 3.332

4.  Volumes of brain structures in twins discordant for schizophrenia.

Authors:  W F Baaré; C J van Oel; H E Hulshoff Pol; H G Schnack; S Durston; M M Sitskoorn; R S Kahn
Journal:  Arch Gen Psychiatry       Date:  2001-01

5.  A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes.

Authors:  Til Wykes; Vyv Huddy; Caroline Cellard; Susan R McGurk; Pál Czobor
Journal:  Am J Psychiatry       Date:  2011-03-15       Impact factor: 18.112

Review 6.  Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

Authors:  M F Green; R S Kern; D L Braff; J Mintz
Journal:  Schizophr Bull       Date:  2000       Impact factor: 9.306

Review 7.  Behavioural studies of spatial working memory dysfunction in schizophrenia: a quantitative literature review.

Authors:  Danijela Piskulic; James S Olver; Trevor R Norman; Paul Maruff
Journal:  Psychiatry Res       Date:  2007-02-12       Impact factor: 3.222

Review 8.  Neuropsychological impairments in schizophrenia: Integration of performance-based and brain imaging findings.

Authors:  Abraham Reichenberg; Philip D Harvey
Journal:  Psychol Bull       Date:  2007-09       Impact factor: 17.737

9.  Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.

Authors:  Richard S E Keefe; Robert M Bilder; Sonia M Davis; Philip D Harvey; Barton W Palmer; James M Gold; Herbert Y Meltzer; Michael F Green; George Capuano; T Scott Stroup; Joseph P McEvoy; Marvin S Swartz; Robert A Rosenheck; Diana O Perkins; Clarence E Davis; John K Hsiao; Jeffrey A Lieberman
Journal:  Arch Gen Psychiatry       Date:  2007-06

10.  Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine.

Authors:  Akihiro Mouri; Yukihiro Noda; Akihiro Noda; Tomonobu Nakamura; Takanobu Tokura; Yoshimitsu Yura; Atsumi Nitta; Hiroshi Furukawa; Toshitaka Nabeshima
Journal:  Mol Pharmacol       Date:  2007-03-07       Impact factor: 4.436

View more
  27 in total

1.  Predictors of virtual radial arm maze performance in adolescent Italian children.

Authors:  Joe M Braun; Roberto Lucchini; David C Bellinger; Elaine Hoffman; Marco Nazzaro; Donald R Smith; Robert O Wright
Journal:  Neurotoxicology       Date:  2012-07-06       Impact factor: 4.294

Review 2.  Brave new worlds--review and update on virtual reality assessment and treatment in psychosis.

Authors:  Wim Veling; Steffen Moritz; Mark van der Gaag
Journal:  Schizophr Bull       Date:  2014-09-05       Impact factor: 9.306

3.  Selective overexpression of dopamine D3 receptors in the striatum disrupts motivation but not cognition.

Authors:  Eleanor H Simpson; Vanessa Winiger; Dominik K Biezonski; Iram Haq; Eric R Kandel; Christoph Kellendonk
Journal:  Biol Psychiatry       Date:  2013-12-05       Impact factor: 13.382

4.  Hippocampal-dorsolateral prefrontal coupling as a species-conserved cognitive mechanism: a human translational imaging study.

Authors:  Florian Bähner; Charmaine Demanuele; Janina Schweiger; Martin F Gerchen; Vera Zamoscik; Kai Ueltzhöffer; Tim Hahn; Patric Meyer; Herta Flor; Daniel Durstewitz; Heike Tost; Peter Kirsch; Michael M Plichta; Andreas Meyer-Lindenberg
Journal:  Neuropsychopharmacology       Date:  2015-01-12       Impact factor: 7.853

Review 5.  Developing treatments for cognitive deficits in schizophrenia: the challenge of translation.

Authors:  J W Young; M A Geyer
Journal:  J Psychopharmacol       Date:  2014-12-16       Impact factor: 4.153

6.  Regulation of sustained attention, false alarm responding and implementation of conditional rules by prefrontal GABAA transmission: comparison with NMDA transmission.

Authors:  Meagan L Auger; Juliet Meccia; Stan B Floresco
Journal:  Psychopharmacology (Berl)       Date:  2017-06-24       Impact factor: 4.530

7.  Variable maternal stress in rats alters locomotor activity, social behavior, and recognition memory in the adult offspring.

Authors:  Christina A Wilson; Alvin V Terry
Journal:  Pharmacol Biochem Behav       Date:  2012-12-31       Impact factor: 3.533

Review 8.  Global cerebral ischemia: synaptic and cognitive dysfunction.

Authors:  Jake T Neumann; Charles H Cohan; Kunjan R Dave; Clinton B Wright; Miguel A Perez-Pinzon
Journal:  Curr Drug Targets       Date:  2013-01-01       Impact factor: 3.465

Review 9.  Modeling neurodevelopmental cognitive deficits in tasks with cross-species translational validity.

Authors:  Z A Cope; S B Powell; J W Young
Journal:  Genes Brain Behav       Date:  2016-01       Impact factor: 3.449

Review 10.  Assessing Cognition Outside of the Clinic: Smartphones and Sensors for Cognitive Assessment Across Diverse Psychiatric Disorders.

Authors:  Ryan Hays; Philip Henson; Hannah Wisniewski; Victoria Hendel; Aditya Vaidyam; John Torous
Journal:  Psychiatr Clin North Am       Date:  2019-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.